Search & Filter

The U.S. Food and Drug Administration said late Wednesday that it expects to complete its long-awaited safety review of abortion pills by mid-December and issue a report evaluating the results by March 2027.

Women in states with post-Dobbs abortion bans, including Louisiana, face a 5.4% increase in annual out-of-pocket health insurance premium costs, with even higher increases for Black and Hispanic women. This rise is linked to insurers passing on costs associated with pregnancy and childbirth complications that have increased due to abortion restrictions in these states.

Louisiana Attorney General Liz Murrill and her counterparts in Arkansas and Alabama announced Wednesday they are suing three Democratic-led states over laws that grant immunity to doctors who prescribe abortion-inducing medication to people in states where it is illegal. The lawsuit, filed directly with the U.S. Supreme Court, alleges laws in California, Massachusetts and New […]

Louisiana Attorney General Liz Murrill appeared before the 5th Circuit Court of Appeals in New Orleans seeking to end the federal policy allowing abortion drugs to be prescribed via telehealth without an in-person doctor visit. She argues that the Biden-era FDA policy enabling mail delivery of mifepristone circumvents state abortion bans and poses risks to women, urging the FDA to reinstate pre-2023 rules despite ongoing federal court challenges and a pending FDA safety study.

Planned Parenthood Great Plains plans to open a new clinic in New Orleans later this year, providing contraception, STI testing, gender-affirming care, and other services but not abortion. Louisiana officials, including Attorney General Liz Murrill and Louisiana Right to Life, oppose the reopening, citing state abortion bans and legal challenges to telehealth abortion services.

The 5th Circuit Court of Appeals blocked a 2023 FDA rule allowing mifepristone to be dispensed without an in-person visit, affecting access to abortion medication nationwide. Louisiana Attorney General Liz Murrill sued the FDA to strike down this provision, and the court's decision supports Louisiana's abortion ban by requiring in-person dispensing and citing state Medicaid costs for emergency care related to the drug.

Louisiana Attorney General Liz Murrill has asked the U.S. 5th Circuit Court of Appeals to halt the FDA's policy allowing telehealth prescriptions of the abortion drug mifepristone while her lawsuit to overturn the policy is on hold. Despite Louisiana's near-total abortion ban, about 1,000 abortions per month continue in the state, largely due to telehealth prescriptions, which Murrill argues cause irreparable harm to Louisiana.

Louisiana House Concurrent Resolution 26, introduced by Rep. Emily Chenevert, urges the state Board of Elementary and Secondary Education to include prenatal development content in public school curricula, sparking criticism that it pushes an anti-abortion agenda. Critics and reproductive rights advocates in Louisiana argue the resolution uses vague language to introduce political propaganda and resembles similar efforts in other states to mandate anti-abortion instructional materials in schools.

A federal judge in Louisiana has preserved telehealth access to abortion medication, pausing the state's lawsuit against the FDA's 2023 rule allowing telehealth prescriptions of mifepristone until the FDA completes a safety review. Louisiana Attorney General Liz Murrill sued to strike down the provision, arguing it causes harm to the state, but the judge left the motion open for refiling after the FDA review.

Louisiana Attorney General Liz Murrill has asked a federal judge to end the FDA policy allowing abortion medication mifepristone to be prescribed via telehealth, challenging the drug's availability to Louisiana residents after the state's near-total abortion ban. The case, heard in Lafayette, could determine whether out-of-state telehealth prescriptions for abortion pills remain accessible to people in Louisiana, where nearly 1,000 medication abortions per month are reported from out-of-state sources despite the ban.

Louisiana Attorney General Liz Murrill filed a lawsuit challenging the FDA's 2023 rule allowing mifepristone to be prescribed via telehealth, seeking to reinstate an in-person dispensing requirement. The case, which also involves a woman alleging reproductive coercion by her ex-boyfriend, could impact medication abortion access nationwide and is set for a preliminary injunction hearing before U.S. District Judge David Joseph.

Two drug manufacturers, GenBioPro and Danco, have asked a federal judge to intervene and dismiss a Louisiana-led lawsuit seeking to stop the mailing of the abortion drug mifepristone. Louisiana requested a preliminary injunction to halt a 2023 regulatory change allowing mifepristone to be mailed, with a hearing scheduled for February 24.

The Trump administration has requested a federal judge in Louisiana to pause ruling on the state's lawsuit seeking to end the FDA policy allowing abortion medication to be prescribed without an in-person visit. Louisiana Attorney General Liz Murrill filed the suit and has indicted out-of-state doctors for prescribing and shipping abortion drugs to Louisiana residents, citing increased abortions in the state since the reversal of Roe v. Wade.

Abortion opponents are targeting medication abortion, particularly the drugs mifepristone and misoprostol, as their top priority for restriction in 2026 due to their growing use and availability via telehealth and mail. Louisiana Attorney General Liz Murrill highlighted that abortions have increased in Louisiana despite legal restrictions, attributing this rise largely to easier access to medication abortion.

Louisiana Attorney General Liz Murrill has indicted California doctor Rémy Coeytaux in St. Tammany Parish for allegedly sending abortion pills to Louisiana in violation of state law, classifying mifepristone and misoprostol as Schedule IV controlled substances with criminal penalties. Murrill has requested extradition to bring Coeytaux to Louisiana, marking the second case of an out-of-state physician charged for providing abortion medication to Louisiana residents amid state efforts to enforce strict abortion drug regulations.

Dr. Evelyn Griffin, a Baton Rouge obstetrician and gynecologist aligned with anti-abortion forces and skeptical of vaccines, was appointed Louisiana's surgeon general by Gov. Jeff Landry. Griffin, who serves on the CDC's vaccine advisory panel under U.S. Health Secretary Robert F. Kennedy Jr., supports Louisiana's strict abortion ban and has opposed COVID-19 vaccine mandates in the state.

The Clinic NOLA opened in Uptown New Orleans on November 1 to fill the gap in sexual and reproductive healthcare left by the closure of Planned Parenthood's two Louisiana health centers. The clinic offers STI testing and treatment, birth control, PrEP, and well-woman exams, and plans to expand services to include prenatal care and miscarriage management up to 12 weeks.

Louisiana Attorney General Liz Murrill filed a lawsuit against the U.S. Food and Drug Administration seeking to reverse 2023 regulations that allow abortion medication mifepristone to be prescribed and mailed without an in-person doctor visit. The suit also involves efforts to prosecute out-of-state doctors who mailed abortion drugs to Louisiana residents, and supports a state law classifying mifepristone and misoprostol as Schedule IV controlled substances, imposing stricter controls on their distribution.